tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NKTR Stock Latest News

Coterra, Ovintiv, Nektar, Co-Diagnostics, Fluence: Trending by Analysts
Weekend UpdatesCoterra, Ovintiv, Nektar, Co-Diagnostics, Fluence: Trending by Analysts
5d ago
OVV
CODX
Autodesk upgraded, Nio downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Autodesk upgraded, Nio downgraded: Wall Street’s top analyst calls
8d ago
KD
PD
Nektar price target raised to $121 from $99 at Jefferies
PremiumThe Fly
Nektar price target raised to $121 from $99 at Jefferies
8d ago
NKTR
Citi starts Nektar with Buy, opens ‘positive catalyst watch’
PremiumThe Fly
Citi starts Nektar with Buy, opens ‘positive catalyst watch’
8d ago
NKTR
Nektar Therapeutics Announces Chief Legal Officer Departure
PremiumCompany Announcements
Nektar Therapeutics Announces Chief Legal Officer Departure
13d ago
8K
NKTR
Hold Rating Maintained Amid Uncertainty in Rezpeg Trial Outcomes and Ongoing Research
PremiumRatingsHold Rating Maintained Amid Uncertainty in Rezpeg Trial Outcomes and Ongoing Research
16d ago
NKTR
Nektar Therapeutics: Buy Rating Driven by Promising REZPEG Data and Favorable Safety Profile in Alopecia Areata Treatment
Premium
Ratings
Nektar Therapeutics: Buy Rating Driven by Promising REZPEG Data and Favorable Safety Profile in Alopecia Areata Treatment
19d ago
NKTR
Nektar files automatic mixed securities shelf
Premium
The Fly
Nektar files automatic mixed securities shelf
22d ago
NKTR
Nektar Therapeutics Reveals Promising Phase 2b Trial Results
PremiumCompany Announcements
Nektar Therapeutics Reveals Promising Phase 2b Trial Results
24d ago
8K
NKTR
Nektar presents new data from REZOLVE-AD study of ACAAI
PremiumThe Fly
Nektar presents new data from REZOLVE-AD study of ACAAI
25d ago
NKTR
Nektar Therapeutics’ Earnings Call Highlights Robust Growth and Innovation
PremiumCompany Announcements
Nektar Therapeutics’ Earnings Call Highlights Robust Growth and Innovation
25d ago
NKTR
Nektar Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Nektar Therapeutics Reports Q3 2025 Financial Results
27d ago
NKTR
Hold Rating on Nektar Therapeutics Amid Uncertainties in Rezpeg’s Clinical Trials and Market Potential
PremiumRatingsHold Rating on Nektar Therapeutics Amid Uncertainties in Rezpeg’s Clinical Trials and Market Potential
27d ago
NKTR
Nektar reports Q3 adjusted EPS ($1.85), consensus ($2.79)
Premium
The Fly
Nektar reports Q3 adjusted EPS ($1.85), consensus ($2.79)
28d ago
NKTR
Nektar management to meet virtually with B. Riley
Premium
The Fly
Nektar management to meet virtually with B. Riley
28d ago
NKTR
Nektar participates in a conference call with BTIG
PremiumThe Fly
Nektar participates in a conference call with BTIG
28d ago
NKTR
Nektar participates in a conference call with BTIG
PremiumThe Fly
Nektar participates in a conference call with BTIG
29d ago
NKTR
Is NKTR a Buy, Before Earnings?
PremiumPre-Earnings
Is NKTR a Buy, Before Earnings?
1M ago
NKTR
Nektar rumor highlighted in Betaville alert
PremiumThe Fly
Nektar rumor highlighted in Betaville alert
2M ago
NKTR
Nektar litigation hearing against Lilly delayed, says B. Riley
PremiumThe FlyNektar litigation hearing against Lilly delayed, says B. Riley
2M ago
LLY
NKTR
Nektar price target raised to $99 from $69 at Jefferies
Premium
The Fly
Nektar price target raised to $99 from $69 at Jefferies
3M ago
NKTR
Nektar Therapeutics Reveals Promising Phase 2b Study Results
Premium
Company Announcements
Nektar Therapeutics Reveals Promising Phase 2b Study Results
3M ago
8K
NKTR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >